Casses of Antianginal Compounds: Old and New—Therapeutic Implications

1. Eagle KA , Guyton RA , et al. ACC/AHA 1999 Guidelines for coronary artery bypass graft surgery. J Am Coll Cardiol 34:1262-1347, 1999

2. Singh BN. Pharmacological Actions of Certain Cardiac Drugs and Hormones: Focus on Antiarrhythmic Mechanisms. D. Phil. Thesis, 1971; Hertford College & University of Oxford. England. Published also by Futura Publishing Co, Mt Kisco, NY, pp 1-98, 1991

3. Singh BN , Vaughan Williams . The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 39:657-667, 1970

4. Singh BN , Vaughan Williams EM . A third class of antiarrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol 39:675-687, 1970

5. Singh BN . A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. Cardiovasc Res 16:109-119, 1972

6. Solomon AJ , Gersh BJ , McDonald KM , Hastie T. Management of chronic stable angina: Medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from the randomized trials. Ann Intern Med 128:216-223, 1998

7. Yusuf S , Camm AJ . Sinus tachyarrhythmias and specific bradycardic agents-a marriage made in heaven? In press, J Cardiovasc Pharmacol Ther 2003

8. Singh BN , Vanhoutte PM (eds). Selective & Specific If Inhibition in Cardiovascular Disease. Lippincott Williams & Wilkins, London, UK, pp 1-134, 2003

9. Singh BN . Heart rate reduction and morbidity and mortality in cardiovascular disorders. In: Singh BN , Vanhoutte PM (eds). Selective & Specific If Inhibition in Cardiovascular Disease. Lippincott Williams & Wilkins, London, UK, pp 1-134, 2003

10. Fox K. Efficacy of ivabradine in stable angina. In: Singh BN , Vanhoutte PM (eds). Selective & Specific If Inhibition in Cardiovascular Disease. Lippincott Williams & Wilkins, London, UK, pp 1-134, 2003

11. Lopaschuk GD , Rebeyka IM , Allard MF . Metabolic modulation-a means to mend a broken heart. Circulation 105:140-142, 2002

12. Schofield RS , Hill JA . Role of metabolically active drugs in the management of ischemic heart disease. Am J Cardiovasc Drugs 1:23-32, 2001

13. McCormack JG , Stanley WC , Wolff AA . Ranolazine: A novel metabolic modulator for the treatment of angina. Gen Pharmacol 30:639-645, 1998

14. Wolff AA , Rotmensch HH , Stanley WC , Ferrari R. Metabolic approaches to the treament of ischemic heart disease: The clinician's perspective. Heart Failure Reviews. 17:187-203, 2002

15. Dargie HJ , Ford I , Fox KM , Hills WS . Effect of nicorandil on coronary events in patients with stable angina: The Impact of Nicorandil in Angina (IONA) randomized trial. Lancet 359:1269-1275, 2002

16. Lawrence JH , Ivleva I , Shylakhto E. Ompatrilat: Novel vasopeptidase inhibitor with anti-ischemic and anti-anginal activity in a placebo-controlled trial in stable, effortinduced angina pectoris. Eur Heart J 22:291-298, 2001

17. Fuster V , ed. Major challenges in the management of stable angina pectoris: A novel approach with trimetazidine. Am J Cardiovasc Drugs 3:1-33, 2003

18. Lopaschuk GD . Pharmacologic rationale for trimetazidine in the treatment of ischemic heart disease. Am J Cardiovasc Drugs 3:21-26, 2003

19. Jackson G. A metabolic approach to the management of ischemic heart disease. Am J Cardiovasc Drugs 3:27-33, 2003

20. Cocco G , et al. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or dilatizem. J Cardiovasc Pharmacol 20(1):131-138, 1992

21. Rousseau MF , Visser FG , Bax JJ . Ranolazine: Antianginal therapy with a novel mechanism: Placebo-controlled comparison with atenolol. Eur Heart J 15(Suppl): 195-195, 1994

22. Wolff AA , Eadie J , Penman AD . MARISA: Monotherapy Assessment of Ranolazine in Stable Angina. J Am Coll Cardiol 35(Suppl A):408A-408A

23. Heidenreich PA , McDonald KM , Hastie T. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA 281:1927-1936, 1999